| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 19.273 | 52.021 | 100.017 | 144.815 | 164.929 | 178.211 | 136.085 | 125.878 |
| Total Income - EUR | - | - | 19.273 | 52.021 | 100.017 | 144.815 | 164.929 | 178.211 | 136.085 | 125.878 |
| Total Expenses - EUR | - | - | 3.021 | 4.682 | 600 | 1.815 | 3.487 | 15.536 | 26.145 | 27.122 |
| Gross Profit/Loss - EUR | - | - | 16.252 | 47.340 | 99.417 | 143.000 | 161.442 | 162.675 | 109.941 | 98.755 |
| Net Profit/Loss - EUR | - | - | 15.674 | 45.779 | 96.416 | 138.998 | 156.494 | 158.422 | 108.648 | 95.055 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Tie Uroserv Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 41.461 | 44.670 | 30.169 | 15.715 |
| Current Assets | - | - | 17.317 | 50.427 | 97.534 | 210.232 | 293.144 | 133.586 | 93.795 | 84.627 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Receivables | - | - | 0 | 35.678 | 59.249 | 105.079 | 227.487 | 90.714 | 87.708 | 74.360 |
| Cash | - | - | 17.317 | 14.748 | 38.285 | 105.153 | 65.657 | 42.872 | 6.081 | 10.267 |
| Shareholders Funds | - | - | 15.718 | 45.865 | 96.501 | 139.080 | 292.490 | 163.967 | 114.176 | 95.135 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.599 | 4.562 | 1.033 | 71.152 | 42.115 | 14.289 | 9.788 | 5.207 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tie Uroserv Med Srl